Triglyceride Glucose Index for Predicting Major Adverse Cardiovascular Events in Chinese Patients with Hypertension

Fomin Zhang1, Rena Kadierding1, Shihan Zhang1

  • 1Thoracic Clinical College, 12610Tianjin Medical University, Tianjin, China.

Angiology
|May 27, 2022
PubMed

Insights

The triglyceride glucose (TyG) index can predict major adverse cardiovascular events (MACE) in high-risk hypertensive patients. A higher TyG index indicates an increased risk of MACE development.

Area of Science:

  • Cardiology
  • Metabolic Syndrome Research
  • Hypertension Management

Background:

  • Cardiovascular disease remains a leading cause of mortality globally.
  • Hypertension is a major risk factor for cardiovascular events.
  • Identifying reliable prognostic markers for cardiovascular risk in hypertensive populations is crucial.

Purpose of the Study:

  • To investigate the prognostic value of the triglyceride glucose (TyG) index for major adverse cardiovascular events (MACE).
  • To assess the predictive capability of the TyG index in high-risk Chinese hypertensive patients.

Main Methods:

  • A longitudinal cohort study involving 2250 high-risk hypertensive patients from Tianjin, China.
  • Patients were categorized into low-TyG (≤8.87) and high-TyG (>8.87) index groups.
  • Univariate and multivariate Cox regression analyses were employed to evaluate the association between TyG index and MACE.

Main Results:

  • The high-TyG group exhibited a significantly higher risk of MACE (HR: 1.313, 95% CI: 1.010–1.708) compared to the low-TyG group.
  • The predictive value of the TyG index for MACE was more pronounced in subgroups of patients aged ≤65 years and males.
  • The TyG index demonstrated an independent association with the occurrence of MACE after adjusting for other risk factors.

Conclusions:

  • The triglyceride glucose (TyG) index serves as a valuable and independent indicator for predicting major adverse cardiovascular events (MACE) in hypertensive patients.
  • The TyG index may aid in risk stratification and management strategies for hypertensive individuals at high cardiovascular risk.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
304
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
134
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
64
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
47
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
230
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
72